Showing 1 - 6 results of 6 for search 'Teixeira MM', query time: 0.04s
Refine Results
-
1
The Clinical Features, Pathogenesis and Methotrexate Therapy of Chronic Chikungunya Arthritis by Amaral, JK, Taylor, PC, Teixeira, MM, Morrison, TE, Schoen, RT
Published 2019Journal article -
2
Ionizable Lipid Nanoparticle-Mediated TRAIL mRNA Delivery in the Tumor Microenvironment to Inhibit Colon Cancer Progression by da Silva WN, Carvalho Costa PA, Scalzo Júnior SRA, Ferreira HAS, Prazeres PHDM, Campos CLV, Rodrigues Alves MT, Alves da Silva NJ, de Castro Santos AL, Guimarães LC, Ferris MEC, Thatte A, Hamilton A, Bicalho KA, Lobo AO, Santiago HDC, da Silva Barcelos L, Figueiredo MM, Teixeira MM, Vasconcelos Costa V, Mitchell MJ, Frézard F, Pires Goulart Guimaraes P
Published 2024-03-01
Article -
3
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial by Luvira, V, Schilling, WHK, Jittamala, P, Watson, JA, Boyd, S, Siripoon, T, Ngamprasertchai, T, Almeida, PJ, Ekkapongpisit, M, Cruz, C, Callery, JJ, Singh, S, Tuntipaiboontana, R, Kruabkontho, V, Ngernseng, T, Tubprasert, J, Abdad, MY, Keayarsa, S, Madmanee, W, Aguiar, RS, Santos, FM, Hanboonkunupakarn, P, Hanboonkunupakarn, B, Poovorawan, K, Imwong, M, Taylor, WRJ, Chotivanich, V, Chotivanich, K, Pukrittayakamee, S, Dondorp, AM, Day, NPJ, Teixeira, MM, Piyaphanee, W, Phumratanaprapin, W, White, NJ
Published 2024Journal article -
4
Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV) by Schilling, WHK, Jittamala, P, Watson, JA, Ekkapongpisit, M, Siripoon, T, Ngamprasertchai, T, Luvira, V, Pongwilai, S, Cruz, CV, Callery, JJ, Boyd, S, Kruabkontho, V, Ngernseng, T, Tubprasert, J, Abdad, MY, Piaraksa, N, Suwannasin, K, Hanboonkunupakarn, P, Hanboonkunupakarn, B, Sookprome, S, Poovorawan, K, Thaipadungpanit, J, Blacksell, S, Imwong, M, Tarning, J, Taylor, WRJ, Chotivanich, V, Sangketchon, C, Ruksakul, W, Chotivanich, K, Teixeira, MM, Pukrittayakamee, S, Dondorp, AM, Day, NPJ, Piyaphanee, W, Phumratanaprapin, W, White, NJ
Published 2023Journal article -
5
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adap... by Schilling, WHK, Jittamala, P, Watson, JA, Boyd, S, Luvira, V, Siripoon, T, Ngamprasertchai, T, Batty, EM, Cruz, C, Callery, JJ, Singh, S, Saroj, M, Kruabkontho, V, Ngernseng, T, Tanglakmankhong, N, Tubprasert, J, Abdad, MY, Madmanee, W, Kouhathong, J, Suwannasin, K, Pagornrat, W, Piaraksa, N, Hanboonkunupakarn, P, Hanboonkunupakarn, B, Poovorawan, K, Potaporn, M, Srisubat, A, Loharjun, B, Taylor, WRJ, Chotivanich, V, Chotivanich, K, Imwong, M, Pukrittayakamee, S, Dondorp, AM, Day, NPJ, Teixeira, MM, Piyaphanee, W, Phumratanaprapin, W, White, NJ
Published 2023Journal article -
6
Clinical antiviral efficacy of remdesivir in coronavirus disease 2019: an open-label, randomized controlled adaptive platform trial (PLATCOV) by Jittamala, P, Schilling, WHK, Watson, JA, Luvira, V, Siripoon, T, Ngamprasertchai, T, Almeida, PJ, Ekkapongpisit, M, Cruz, C, Callery, JJ, Boyd, S, Anunsittichai, O, Hongsuwan, M, Singhaboot, Y, Pagornrat, W, Tuntipaiboontana, R, Kruabkontho, V, Ngernseng, T, Tubprasert, J, Abdad, MY, Keayarsa, S, Madmanee, W, Aguiar, RS, Santos, FM, Batty, EM, Hanboonkunupakarn, P, Hanboonkunupakarn, B, Sookprome, S, Poovorawan, K, Imwong, M, Taylor, WRJ, Chotivanich, V, Sangketchon, C, Ruksakul, W, Chotivanich, K, Pukrittayakamee, S, Dondorp, AM, Day, NPJ, Teixeira, MM, Piyaphanee, W, Phumratanaprapin, W, White, NJ
Published 2023Journal article